Insights

Innovative Oncology Platform Brenus Pharma's next-generation allogeneic immunotherapy platform offers unique, potent, and diverse tumor-targeting solutions, creating opportunities to collaborate with larger biotech or pharma companies seeking advanced cancer treatments.

Strong Funding Momentum Recent successful funding rounds totaling over $27 million demonstrate investor confidence, providing a foundation for potential licensing, partnership, or co-development opportunities within its advancing clinical pipeline.

Award-Winning Status Recognized as the Best Biotech Startup in France for 2024, Brenus Pharma's prestige could serve as a leverage point for strategic alliances with organizations looking to associate with innovative and award-winning firms.

Growing Clinical Pipeline With the recent launch of the STC platform and ongoing preclinical and clinical development, there are multiple stages for partnership or service opportunities, including clinical collaborations and supply chain engagement.

Focus on Solid Tumors Specializing in therapies for hard-to-treat solid tumors such as colorectal cancer presents a strategic avenue for companies in oncology looking to expand into first-in-class immunotherapies and tumor-antigen targeting solutions.

Brenus Pharma Tech Stack

Brenus Pharma uses 8 technology products and services including Varnish, WordPress, MySQL, and more. Explore Brenus Pharma's tech stack below.

Varnish

Caching

WordPress

Content Management System

MySQL

Database

dc.js

Javascript Graphics

parallax.js

Javascript Libraries

Priority Hints

Performance

Google Analytics

Web Analytics

Apache HTTP Server

Web Servers

Brenus Pharma Email Formats	Example	Percentage
FLast@brenus-pharma.com	JDoe@brenus-pharma.com	45%
First@brenus-pharma.com	John@brenus-pharma.com	5%
FLast@brenus-pharma.com	JDoe@brenus-pharma.com	45%
First@brenus-pharma.com	John@brenus-pharma.com	5%

Brenus Pharma Email Formats

Example

Percentage

FLast@brenus-pharma.com

JDoe@brenus-pharma.com

45%

First@brenus-pharma.com

John@brenus-pharma.com

FLast@brenus-pharma.com

JDoe@brenus-pharma.com

45%

First@brenus-pharma.com

John@brenus-pharma.com

Frequently Asked Questions

Where is Brenus Pharma's headquarters located?

Brenus Pharma's main headquarters is located at Lyon, FR. The company has employees across 3 continents, including EuropeAsiaNorth America.

What is Brenus Pharma's official website and social media links?

Brenus Pharma's official website is brenus-pharma.com and has social profiles on LinkedIn Crunchbase.

What is Brenus Pharma's SIC code NAICS code?

Brenus Pharma's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Brenus Pharma have currently?

As of October 2025, Brenus Pharma has approximately 20 employees across 3 continents, including EuropeAsiaNorth America. Key team members include Chief Executive Officer: P. B.Chief Scientific Officer: B. P.Head Of Asset Management: A. M.. Explore Brenus Pharma's employee directory with LeadIQ.

What industry does Brenus Pharma belong to?

Brenus Pharma operates in the Biotechnology Research industry.

What technology does Brenus Pharma use?

Brenus Pharma's tech stack includes VarnishWordPressMySQLdc.jsparallax.jsPriority HintsGoogle AnalyticsApache HTTP Server.

What is Brenus Pharma's email format?

Brenus Pharma's email format typically follows the pattern of FLast@brenus-pharma.com. Find more Brenus Pharma email formats with LeadIQ.

When was Brenus Pharma founded?

Brenus Pharma was founded in 2019.

Brenus Pharma

Q: What is Brenus Pharma's official website and social media links?

Brenus Pharma's official website is brenus-pharma.com. Brenus Pharma has social profiles on LinkedIn.

Q: How many employees does Brenus Pharma have currently?

Brenus Pharma has approximately 20 employees.

Q: What technology does Brenus Pharma use?

Brenus Pharma's tech stack includes jQuery Migrate, Microsoft 365, Apache HTTP Server, Elementor, Apache.

Biotechnology ResearchLyon, France11-50 Employees

Brenus Pharma is a pioneering clinical stage biotech aiming to prevent cancer recurrence, the main challenge for solid tumors - causing 10M deaths each year worldwide.

We developped a next-generation cancer treatment, thanks to our “off-the-shelf” therapeutic platform. 

Our lead candidate is a proteomic-driven immunotherapy targetting colorectal cancer (CRC), the 2nd deadliest cancer worldwide.

	- Our allogeneic platform generates therapeutics that efficiently educate the immune system, with more potent, diverse and novel targets than any existing therapies. (Characterized by advanced multiomics technologies) 

	- We overcome limitations of several technologies such as mRNA vaccines thanks to our enhanced immunogenicity and standardized GMP manufacturing: we keep control of costs and supply. 

Awarded “Best Biotech Startup” in 2024 in France, we recently closed a $25M SERIES A to accelerate our clinical development.

We are currently envisaging clinical collaborations.

Brenus Pharma sets a new paradigm in oncology, by giving back to patients the ability to fight against their disease.

Insights

Similar companies to Brenus Pharma

Roche

Bristol Myers Squibb

Sanofi

Johnson & Johnson

Merck

Pfizer

AstraZeneca

AbbVie

Biogen

Novartis

Bayer

Amgen

Brenus Pharma Tech Stack

Media & News

Brenus Pharma receives financing of $27.6M in funding round.

Brenus Pharma recognized as BIG Start-up of the Year on Jun 17th '24.

Brenus Pharma launches STC platform.

Brenus Pharma receives financing of $5.45M.

Brenus Pharma is developing first-in-class tumor-antigens focused immunotherapies for solid tumors’ treatment.

Brenus Pharma partners with InSphero AG.

Brenus Pharma receives financing of $4.32M in Seed.

Brenus Pharma's Email Address Formats